↓ Skip to main content

Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial

Overview of attention for article published in Critical Care, August 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
150 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial
Published in
Critical Care, August 2008
DOI 10.1186/cc6999
Pubmed ID
Authors

Jon Pérez-Bárcena, Juan A Llompart-Pou, Javier Homar, Josep M Abadal, Joan M Raurich, Guillem Frontera, Marta Brell, Javier Ibáñez, Jordi Ibáñez

Abstract

Experimental research has demonstrated that the level of neuroprotection conferred by the various barbiturates is not equal. Until now no controlled studies have been conducted to compare their effectiveness, even though the Brain Trauma Foundation Guidelines recommend that such studies be undertaken. The objectives of the present study were to assess the effectiveness of pentobarbital and thiopental in terms of controlling refractory intracranial hypertension in patients with severe traumatic brain injury, and to evaluate the adverse effects of treatment.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 3 2%
United States 3 2%
Brazil 3 2%
Canada 1 <1%
Unknown 140 93%

Demographic breakdown

Readers by professional status Count As %
Other 30 20%
Researcher 23 15%
Student > Bachelor 18 12%
Student > Postgraduate 13 9%
Student > Ph. D. Student 9 6%
Other 31 21%
Unknown 26 17%
Readers by discipline Count As %
Medicine and Dentistry 85 57%
Neuroscience 10 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Biochemistry, Genetics and Molecular Biology 4 3%
Nursing and Health Professions 4 3%
Other 11 7%
Unknown 31 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2020.
All research outputs
#4,836,164
of 25,374,917 outputs
Outputs from Critical Care
#3,282
of 6,554 outputs
Outputs of similar age
#17,053
of 95,344 outputs
Outputs of similar age from Critical Care
#6
of 22 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.